FDA Approves Liga-Chem Bio’s IND for Novel ADC Cancer Therapy
Liga-Chem BioSciences announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its…
Ligachem
2 개의 기사가 있습니다.
Liga-Chem Licenses ADC Technology to Japan’s Ono Pharmaceutical in USD 700M Deal
Liga-Chem Biosciences announced on the 10th that it had signed two licensing agreements with Ono Pharmaceutical, a leading…